PEAR
Pear Therapeutics, Inc. Class A Common Stock
PEAR
PEAR
Delisted
PEAR was delisted on the 18th of April, 2023.
49 hedge funds and large institutions have $385M invested in Pear Therapeutics, Inc. Class A Common Stock in 2022 Q1 according to their latest regulatory filings, with 26 funds opening new positions, 5 increasing their positions, 4 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
17% less capital invested
Capital invested by funds: $464M → $385M (-$79.2M)
Holders
49
Holding in Top 10
6
Calls
–
Puts
–
Top Buyers
| 1 | +$2.14M | |
| 2 | +$2.1M | |
| 3 | +$1.14M | |
| 4 |
HF
HRT Financial
New York
|
+$761K |
| 5 |
ECM
ExodusPoint Capital Management
New York
|
+$624K |
Top Sellers
| 1 | -$225K | |
| 2 | -$24.9K | |
| 3 | -$6.62K | |
| 4 |
Osaic Holdings
Scottsdale,
Arizona
|
-$6K |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$5.56K |